Skip to content

Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients

Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients; Role of Natriuresis

Status
Withdrawn
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01074918
Enrollment
0
Registered
2010-02-24
Start date
2009-09-30
Completion date
2012-12-31
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Pre-hypertension

Keywords

Pre-hypertension, Hypertension

Brief summary

The goal of this study is to compare the effects of Potassium Magnesium Citrate to Potassium Chloride on blood pressure among patients with pre-hypertension or mild hypertension. We will also test whether Potassium Magnesium Citrate increases excretion of large amounts of sodium in the urine.

Interventions

DRUGPotassium, Magnesium, Citrate

Potassium MAgnesium Citrate - 30 mEq potassium, 15 mEq Magnesium, 45 mEq Citrate in a powder mixture twice a day, mixed with a glass of water.

DRUGPotassium Chloride

Potassium Chloride

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to 95 Years
Healthy volunteers
Yes

Inclusion criteria

* Age greater than 21 years * BMI \> 18.5 kg/m2 and \< 40 kg/m2 * Prehypertension and mild hypertension: BP systolic 120-159 mmHg, diastolic 80-95 mmHg * Must agree to limit lifestyle changes including: 1) embarking on a new exercise or weight reduction program 2) altering alcohol intake during the trial.

Exclusion criteria

* Taking blood pressure lowering medication * Diabetes mellitus * Renal disease * Active cardiac disease * Active liver disease * Chronic diarrhea * Chronic NSAID use * Active or suspected drug use * Uncontrolled psychiatric disease * HIV infection * Missed more than 20% of clinic visits in the last yr * Prescription of diuretics for any reason * A patient taking nutritional supplements including multivitamins that is unwilling to discontinue them,\\ * Consumption of greater than 14 alcoholic beverages per week

Design outcomes

Primary

MeasureTime frameDescription
Blood Pressure8 weeksWe have estimated to detect a 4 mmHg difference, with a standard deviation estimated at 8 mmHg.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026